|
|
Home - Ortho-McNeil Neurologics® has products for Alzheimer’s disease, epilepsy,
and migraine prevention and treatment.
|
Our Company - Ortho-McNeil Neurologics® is a US company focused on providing and advancing solutions
that improve neurological health.
|
 |
Our History - Ortho-McNeil Neurologics® emerged in April 2005 as a company solely focused on
neurological health.
|
|
Our Credo - At Ortho-McNeil Neurologics® we believe our first responsibility is to all those who
use our products and services.
|
|
Career Opportunities
- Ortho-McNeil Neurologics® offers challenging opportunities within
one of the world’s leading pharmaceutical corporations.
|
|
|
Ortho-McNeil Janssen Scientific Affairs,
LLC Outcomes Research Fellowship - Ortho-McNeil Janssen
two-year fellowship program provides training and exposure to the
various aspects of outcomes research in both the academic and industry
settings.
|
|
Patient Assistance
- Access2wellness.com, sponsored by Johnson & Johnson Health Care
Systems Inc., provides a single entry point for a broad selection of
patient assistance programs that offer more than 1,000 prescription
medications, for free or at a discount, to people who qualify.
|
|
Driving Directions
|
Innovation & Research
- Ortho-McNeil Neurologics® is positioned to provide and advance solutions
that improve neurological health.
|
Our Products - Ortho-McNeil Neurologics® has RAZADYNE® ER (galantamine hydrobromide), TOPAMAX® (topiramate), and AXERT® (almotriptan malate).
|
|
RAZADYNE® ER
- Ortho-McNeil Neurologics® has RAZADYNE® ER (galantamine hydrobromide)
|
|
TOPAMAX® - Epilepsy
- Ortho-McNeil Neurologics® has TOPAMAX (topiramate)
|
|
TOPAMAX® - Migraine
- Ortho-McNeil Neurologics® has TOPAMAX (topiramate)
|
|
AXERT® - Ortho-McNeil Neurologics® has AXERT® (almotriptan malate)
|
|
Rx for Safety - Ortho-McNeil Neurologics® patient guide to the safe use of prescription medicines.
|
Therapeutic Areas
- Ortho-McNeil Neurologics® has products for Alzheimer's
disease, epilepsy, and migraine prevention and treatment.
|
|
Alzheimer’s disease - Ortho-McNeil Neurologics® has a product for Alzheimer's disease.
|
|
Epilepsy - Ortho-McNeil Neurologics®
has a product for epilepsy, which involves recurring seizures without
a specific trigger or cause.
|
|
Migraine Prevention and Migraine
Treatment - Ortho-McNeil Neurologics® has migraine prevention
and migraine-treatment medicines.
|
Transparency
|
|
Physician Payment
|
|
Medical Education
|
|
Charitable Contributions
|
Our Giving
|
|
Our Focus Areas
|
|
Request Requirements
|
|
FAQs
|
|
Submit Request
|
|
Contact Us
|
Medical Education
|
|
Guidelines
|
|
Forms
|
|
FAQs
|
|
Submit/View Request
|
|
Quick Reference Guide
|
|
Contact Us
|
News Center - Read
recent news releases issued by Ortho-McNeil Neurologics®
|
|
Media Resources - Ortho-McNeil Neurologics® provides resource materials for members of the media.
|
Contact Us - We are
happy to answer your questions. Contact Ortho-McNeil Neurologics® by phone.
|
Privacy Policy
Legal Notice
Tell a Friend
Global Resources
|
State Regulations
- Ortho-McNeil Neurologics® is committed to a culture that embraces healthcare compliance as the right thing to do.
|
|
California
|
|
Vermont
|
Back to Top
|
|
|
|
|
IMPORTANT SAFETY INFORMATION ABOUT RAZADYNE® ER (galantamine HBr)
In clinical trials, the most frequent adverse events with RAZADYNE® ER were similar to the twice-daily formulation
of galantamine HBr. With the twice-daily formulation of galantamine HBr, the most common side effects were nausea,
vomiting, diarrhea, loss of appetite, and weight loss. Typically these side effects were mild and temporary.
RAZADYNE® ER may not be for everyone. Some people experience a slowed heart rate, which may lead
to fainting. Serious stomach problems can occur in people taking medications such as nonsteroidal
anti-inflammatory drugs (NSAIDs) or those at risk for stomach ulcers.
Please see full US Prescribing Information.
|
|
Back to Top
|
|
|
IMPORTANT SAFETY INFORMATION ABOUT TOPAMAX® Epilepsy
Serious risks associated with TOPAMAX® include lowered bicarbonate levels in the blood resulting in an increase in the acidity of the blood (metabolic acidosis). Symptoms could include hyperventilation (rapid, deep breathing), tiredness, loss of appetite, irregular heartbeat or changes in the level of alertness. Call your doctor immediately if you get these symptoms. Your doctor may want to do simple blood tests. Chronic, untreated metabolic acidosis may increase the risk for kidney stones or bone disease.
Other serious risks include decreased sweating, increased body temperature, kidney stones, sleepiness, dizziness, confusion, difficulty concentrating, and increased eye pressure (glaucoma). Call your doctor immediately if you have any decrease in vision or eye pain. These problems can lead to blindness if not treated right away.
More common side effects are tingling in arms and legs, loss of appetite, tiredness, nausea, diarrhea, taste change and weight loss.
As monotherapy, the most common side effects of TOPAMAX® (in the 400 mg/day group and at a rate higher than the 50 mg/day group) in adults were tingling in arms and legs, weight decrease, sleepiness, loss of appetite, dizziness, and difficulty with memory; and in children, weight decrease, upper respiratory tract infection, tingling in arms and legs, loss of appetite, diarrhea, and mood problems.
In combination with other antiepileptic drugs (AEDs), the most common side effects of TOPAMAX® in adults (200 to 400 mg/day) were sleepiness, dizziness, nervousness, loss of muscle coordination, fatigue, speech disorders and related problems, psychomotor slowing, abnormal vision, difficulty with memory, tingling in arms and legs, and double vision; and in children (5 to 9 mg/kg/day), fatigue, sleepiness, loss of appetite, nervousness, difficulty with concentration/attention, difficulty with memory, aggressive reaction, and weight decrease.
Tell your doctor about other medications you take.
Please see full US Prescribing Information.
|
|
Back to Top
|
|
|
IMPORTANT SAFETY INFORMATION ABOUT TOPAMAX® Migraine
Serious risks associated with TOPAMAX® include lowered bicarbonate levels in the blood resulting in an increase in the acidity of the blood (metabolic acidosis). Symptoms could include hyperventilation (rapid, deep breathing), tiredness, loss of appetite, irregular heartbeat or changes in the level of alertness. Call your doctor immediately if you get these symptoms. Your doctor may want to do simple blood tests. Chronic, untreated metabolic acidosis may increase the risk for kidney stones or bone disease.
Other serious risks include decreased sweating, increased body temperature, kidney stones, sleepiness, dizziness, confusion, difficulty concentrating, and increased eye pressure (glaucoma). Call your doctor immediately if you have any decrease in vision or eye pain. These problems can lead to blindness if not treated right away.
More common side effects are tingling in arms and legs, loss of appetite, tiredness, nausea, diarrhea, taste change and weight loss.
Tell your doctor about other medications you take.
Please see full US Prescribing Information.
|
|
Back to Top
|
|
|
IMPORTANT SAFETY INFORMATION ABOUT AXERT®
AXERT® (almotriptan malate) is a prescription medication for the acute treatment of migraine with or without aura in adults. You should not take AXERT® if you have heart disease, uncontrolled high blood pressure or have ever had heart disease. If you have risk factors for heart disease (high blood pressure, high cholesterol, diabetes, obesity, smoking, family history of heart attack, menopause, or are a male over 40 years of age), or if you are pregnant, nursing, or thinking about becoming pregnant, talk with your doctor before taking AXERT®. Tell your doctor about all prescription and over-the-counter medications you are taking.
AXERT®, like other triptans, may be associated with a potentially life-threatening condition mainly when taken together with selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs), two classes of drugs for depression or other disorders. Common SSRIs are Celexa® (citalopram HBr), Lexapro® (escitalopram oxalate), Paxil® (paroxetine), Prozac®/Sarafem® (fluoxetine), Symbyax® (olanzapine/fluoxetine), Zoloft® (sertraline), and Luvox® (fluvoxamine). Common SNRIs are Cymbalta® (duloxetine) and Effexor® (venlafaxine). If you experience symptoms such as confusion, sweating, flushing, rapid heartbeat, diarrhea, muscle weakness, poor balance, or worsening headache, contact your doctor immediately.
The most common AXERT® side effects are nausea, sleepiness, tingling sensation, headache, and dry mouth. Ask your doctor about side effects, possible drug interactions, and any other important questions you may have before taking AXERT®.
Celexa and Lexapro are registered trademarks of Forest Laboratories. Paxil is a registered trademark of GlaxoSmithKline. Symbyax, Prozac/Sarafem and Cymbalta are registered trademarks of Eli Lilly. Zoloft is a registered trademark of Pfizer. Luvox is a registered trademark of Solvay. Effexor is a registered trademark of Wyeth.
Please see full US Prescribing Information.
|
|
Back to Top
|
|
 |
 |
|
PDF documents require Adobe® Reader® to view.
Click here
to download Adobe® Reader® for free.
|
|
|
|
